The research groups lead by Prof. Dr. Elly Tanaka, Prof. Dr. Marius Ader and Dr. Mike Karl at the DFG-Research Center for Regenerative Therapies Dresden (CRTD) – Cluster of Excellence at TU Dresden, have received funding in the BMBF program “Validation of the technological and societal innovation potential of scientific research – VIP+” with their CLEANSIGHT research team. The research project will focus on validating a retinal cell–based screening platform for fast and efficient identification of small molecules for the treatment of retinal degenerative diseases.
With more than 150 million affected people, retinal degenerative diseases are one of the most frequent causes of visual impairment worldwide. Examples include genetically inherited Retinitis Pigmentosa (RP), and age-related macular degeneration (AMD). The prevalence of AMD is expected to reach epidemic proportions due to an increasingly aging population. There are currently no effective therapies to prevent or cure these diseases.
Retinal diseases are associated with build-up of waste products. Vision loss may occur, for example, when the retinal pigment epithelial cells (RPE), which underlie the neural retina, are impaired in taking up and recycling natural waste products of the retina.
This process, known as phagocytosis, is essential for visual function and survival of our light sensitive retinal neurons, called photoreceptors. Abnormal RPE cell function can lead to retinal degeneration, visual impairment and even loss of sight. Therapeutic compounds modulating RPE functions might prevent vision loss.
”The aim of CLEANSIGHT is to validate a RPE-based screening platform, which we have developed since 2013, to search for classes of compounds that are suitable candidates for the development of novel therapeutics, and bring it to industry standards. RPE cells used in this platform are derived from human stem cells by a patented and very efficient protocol, which made the platform development possible”, explains the research team consisting of Dr. Seba Almedawar (project leader), Dr. Sven Schreiter and Dr. Dominic Eberle, supported by Prof. Elly Tanaka, Prof. Marius Ader and Dr. Mike Karl. A procedure patented by Prof. Tanaka enables the production of large quantities of human RPE cells at uniformly high quality in the laboratory. This constitutes a major advance for the development of a screening platform for new therapeutic substances.
The awarded research grant is part of the new Hightech-Strategy „Innovationen für Deutschland“ of the German Federal Government. The rapid transfer of innovative ideas for products and services aims to strengthen Germany’s leading position as the largest national economy and exporter in Europe.
The Grant Office, CMCB (a service unit that supports CRTD, BIOTEC and B CUBE in the acquisition of third-party funds) and the Technology Transfer Office have both closely coordinated the CLEANSIGHT grant application and continue to offer their support to the project team.
Further information on CLEANSIGHT (Dresdner Transferbrief, Issue 2.16)
http://www.qucosa.de/fileadmin/data/qucosa/documents/20367/transferbrief_ausgabe... (pages 10-11)
Phone: +49 351 458 82065, e-Mail: firstname.lastname@example.org
Founded in 2006, the DFG Research Center for Regenerative Therapies Dresden (CRTD), Cluster of Excellence at the TU Dresden has passed the second phase of the Excellence Initiative which aims at promoting top-level research and improving the quality of German universities and research institutions. The goal of the CRTD is to explore the body's self-healing potential and to develop completely new, regenerative therapies for hitherto incurable diseases. The key areas of research include haematology and immunology, diabetes, neurodegenerative diseases and bone regeneration. At the moment, eight professors and ten group leaders are working at the CRTD – integrated into an interdisciplinary network of 87 members at seven different institutions within Dresden. In addition, 21 partners from industry are supporting the network. The synergies in the network allow for a fast translation of results from basic research to clinical applications.
Franziska Clauß | idw - Informationsdienst Wissenschaft
Reconstructing the richness of pristine oceans funded by the ERC
28.10.2019 | Johannes Gutenberg-Universität Mainz
AI for Understanding and Modelling the Earth System – International Research Team wins ERC Synergy Grant
14.10.2019 | Max-Planck-Institut für Biogeochemie
Conventional light microscopes cannot distinguish structures when they are separated by a distance smaller than, roughly, the wavelength of light. Superresolution microscopy, developed since the 1980s, lifts this limitation, using fluorescent moieties. Scientists at the Max Planck Institute for Polymer Research have now discovered that graphene nano-molecules can be used to improve this microscopy technique. These graphene nano-molecules offer a number of substantial advantages over the materials previously used, making superresolution microscopy even more versatile.
Microscopy is an important investigation method, in physics, biology, medicine, and many other sciences. However, it has one disadvantage: its resolution is...
Nanooptical traps are a promising building block for quantum technologies. Austrian and German scientists have now removed an important obstacle to their practical use. They were able to show that a special form of mechanical vibration heats trapped particles in a very short time and knocks them out of the trap.
By controlling individual atoms, quantum properties can be investigated and made usable for technological applications. For about ten years, physicists have...
An international team of scientists, including three researchers from New Jersey Institute of Technology (NJIT), has shed new light on one of the central mysteries of solar physics: how energy from the Sun is transferred to the star's upper atmosphere, heating it to 1 million degrees Fahrenheit and higher in some regions, temperatures that are vastly hotter than the Sun's surface.
With new images from NJIT's Big Bear Solar Observatory (BBSO), the researchers have revealed in groundbreaking, granular detail what appears to be a likely...
The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM in Dresden has succeeded in using Selective Electron Beam Melting (SEBM) to...
15.11.2019 | Event News
15.11.2019 | Event News
05.11.2019 | Event News
22.11.2019 | Materials Sciences
22.11.2019 | Life Sciences
22.11.2019 | Life Sciences